General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Amgen Inc.(SIGNIFICANT), Bristol-Myers Squibb Company (MODEST), Anthos Therapeutics(MODEST), Intarcia(MODEST), Althera(MODEST), Merck & Co., Inc.(SIGNIFICANT), AstraZeneca(MODEST), Fibrogen(MODEST), Moderna(MODEST), Novo Nordisk Inc.(MODEST), Silence Therapeutics(MODEST) RESEARCH/RESEARCH GRANTS: Eisai(SIGNIFICANT), Intarcia(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), MedImmune, Inc(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Daiichi-Sankyo(SIGNIFICANT), Pfizer Inc(SIGNIFICANT), Medicines Company(SIGNIFICANT), Novartis(SIGNIFICANT), Anthos Therapeutics(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), IONIS(SIGNIFICANT)
